StreetAlpha
13F holdings · Q2 2026

Candriam S.C.A.

Strassen, N4 · files as Candriam S.C.A.
Holdings as of Jun 30, 2026Filed Aug 13, 2026Next filing due Nov 16, 2026CIK 1537014

Candriam S.C.A. reported 660 stocks worth $22.1B in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are NVDA (6.4%), AAPL (4.8%) and MSFT (4.2%). Compared with Q1 2026, the fund added to NVDA, AAPL and GOOGL, trimmed MSFT, MU and LLY and sold out of ASND, ENSG and FUTU.

Reported value$22.1B+15.4% vs last quarter
Stocks held66041 new · 54 sold out
Top 5 weight22.5%spread out
Turnover21%of the portfolio changed
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
NVDA
Nvidia Corporation
$1.4B6.4%7M+14K (+0%)8 of 8
2
AAPL
Apple Inc
$1B4.8%3.6M+129K (+4%)8 of 8
3
MSFT
Microsoft Corp
$939M4.2%2.5M−158K (−6%)8 of 8
4
GOOGL
Alphabet Inc
$936M4.2%2.6M+38K (+1%)8 of 8
5
AVGO
Broadcom Inc
$639M2.9%1.7M+274K (+19%)8 of 8
6
AMZN
Amazon Com Inc
$618M2.8%2.6M+60K (+2%)8 of 8
7
MU
Micron Technology Inc
$488M2.2%423K−91K (−18%)8 of 8
8
LLY
Eli Lilly & Co
$482M2.2%402K−15K (−4%)8 of 8
9
AMD
Advanced Micro Devices Inc
$382M1.7%658K+66K (+11%)8 of 8
10
PANW
Palo Alto Networks Inc
$328M1.5%963K−236K (−20%)8 of 8
🔒 650 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q1 2026, gone in Q2 2026
StockValue last quarterShares sold
ASND
Ascendis Pharma A/s
$52.7M230K
ENSG
Ensign Group Inc
$52.4M260K
TERNS PHARMACEUTICALS INC
$33.3M632K
FUTU
Futu Hldgs Ltd
$20.8M152K
IAG
Iamgold Corp
$19.2M1M

🔒 Free account: see all 30.

Reported value

last 8 quarters
$17.3BQ3 '24
$17.2BQ4 '24
$15.9BQ1 '25
$17.2BQ2 '25
$19BQ3 '25
$20BQ4 '25
$19.2BQ1 '26
$22.1BQ2 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q2 2026

straight from the SEC
FiledFormQuarter
Aug 13, 202613F-HRQ2 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Candriam S.C.A. 13F FAQ

What does Candriam S.C.A. own?

Candriam S.C.A. reported 660 stocks worth $22.1B in its 13F filing for Q2 2026, filed Aug 13, 2026. The table above lists every position in the filing (the top 10 without an account).

What did Candriam S.C.A. buy and sell in Q2 2026?

Compared with Q1 2026: 41 new positions, 290 added to, 280 trimmed and 54 sold out. It sold all of ASND, ENSG and FUTU.

When will Candriam S.C.A. file its next 13F?

Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.

How much is Candriam S.C.A.'s portfolio worth?

The Q2 2026 filing reports $22.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.